The advanced Alzheimer’s blood test is now available at the NRL – the first of its kind in the UAE and wider MENA region. The blood test uses precision biomarker technology to help detect early signs of Alzheimer’s disease, long before noticeable symptoms appear.
Alzheimer’s can begin decades before symptoms such as memory loss or confusion develop. By identifying specific biomarkers in the blood, this test provides valuable insight into changes occurring in the brain, supporting:
Early testing gives patients and families more time to plan, make informed choices, and access the right support when it matters most.
Through the world-class M42 network, patients have exclusive access to advanced Alzheimer's biomarker testing performed by M42's National Reference Laboratory (NRL), delivering accurate results, high-quality testing, and trusted diagnostic insights.
Please complete the form below to access and download the brochure. Your details help us share relevant information and follow-up with any related updates.
